ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 26692 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 26692; 2) Community: the network communities that were significantly associated with the response to NSC 26692; 3) Molecule: the relationships between components within communities and NSC 26692; 4) MDR: the compounds that were significantly associated with the NSC 26692.

NSC Compound Enrichment Correlation
NSC 726217 Combretastatin A4-analogue 0.012942183459279 0.37688476
NSC 743433 8-(4-{4-[6-(4-piperazinoquinazoline)-7-methoxy-2,3,5,11-atetrahydra-1H-benzo[e]pyrrolo[1,2-c][1,4]diazepin-5-one 0.012942183459279 0.37910714
NSC 744688 Null 0.012942183459279 0.61101683
NSC 751605 (E)-N-[4-(1-benzoylpiperidine-4-yl)butyl]-3-(pyridin-3-yl)acrylamide 0.012942183459279 0.19609716
NSC 752506 5-nitro-N-((pyridin-3-yl)methyl)furan-2-carboxamide 0.012942183459279 0.10550958
NSC 755442 Null 0.012942183459279 0.41948613
NSC 762908 2-(4-(methylsulfonyl)phenyl)-6-p-tolyl-4,5-dihydropyridazin-3(2H)-one 0.012942183459279 0.57151041
NSC 123491 L-Cysteine, S-[tris(4-methylphenyl)methyl]- (9CI) 0.0133012546828912 0.325287
NSC 302288 BOHLMANN K2630 0.0133012546828914 0.2875206
NSC 641390 Null 0.0133012546828914 0.33572743
Total:85  Current:26    [First] [Prev] [Next] [Last]